Ironwood Pharmaceuticals
IRWD | NASDAQ
$4.85
+$0.02 (+0.41%)
At close: Nov 16, 2026, 4:00 PM ET
$4.75
-$0.10 (-2.06%)
After-hours:
Nov 16, 2026, 7:30 PM ET
+0.41%
(1D)No price chart data available for 1D timeframe.
Rating
75.8
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #32/1021 (Top 3%)
Key Statistics
Market Data
Market Cap $802.92M
1D Range
4.76 4.92
52W Range
3.04 5.39
Valuation (TTM)
PE 5.39
PB -8.26
EV/EBITDA 2.81
Valuation (NTM)
Forward PE 3.77
Forward PEG 0.01
Price Target $5.00
Cash Flow
FCF Yield 23.1%
SBC Adj. FCF Yield 20.3%
SBC Impact -12.1%
Margins
Gross Margin 99.9%
Operating Margin 62.8%
FCF Margin 46.4%
Growth (CAGR)
Revenue 3Y | 5Y -2.5% |
-0.6%
Dil EPS 3Y | 5Y 133.7% |
-22.6%
FCF 3Y | 5Y -11.0% |
-4.0%
Returns
ROA 51.5%
ROE -93.4%
ROIC 64.0%
Financial Health
Net Cash
$75.17M
Current Ratio 6.51
Interest Coverage 8.27
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its f...
Sector Healthcare
Employees 100
IPO Date Feb 3, 2010
Website www.ironwoodpharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
$0.36
Beat +11.35%
YoY:
+50.00% REV
$133.04M
Beat +9.44%
YoY:
+9.00%Next Earnings
Feb 24, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
2
Consensus
Hold
Price Target
$5.00
Upside
+3.09%
Buy (1)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove IRWD